Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Pinar Ozgen, Kiratli"'
Autor:
Emel Ceylan Günay, Bilge Volkan Salanci, Esra Çiftçi, Pınar Pelin Özcan, Murat Nedim Gülaldı, Pinar Ozgen Kiratli, Tamer Aksoy
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 2, Pp 229-236 (2020)
The aim of this procedure guideline is the standardization of I-123 metaiodobenzylguanidine scintigraphy, F-18 fluorodeoxyglucose, F-18 fluoropheniylalanine, Ga-68 DOTA peptide positron emission tomography/computerized tomography imaging protochols i
Autor:
Bilge Volkan Salanci, Pınar Pelin Özcan, Emel Ceylan Günay, Tamer Aksoy, Pinar Ozgen Kiratli, Murat Nedim Gülaldı
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 2, Pp 237-242 (2020)
This guideline is the updated version of TNTD renal cortical scintigraphy guideline published in 2001. It includes the current recommended patient doses and patient dosimetry according to international guidelines.
Publikováno v:
Clinical Nuclear Medicine. 45:326-329
A girl diagnosed with neuroblastoma at 33 months underwent I-MIBG scan after surgery and chemoradiotherapy. Although MIBG scan showed complete response, the bone marrow biopsy showed refractory disease. Therefore, she underwent Ga-DOTATATE PET/CT, wh
Autor:
Ken Herrmann, Luca Giovanella, Andrea Santos, Jonathan Gear, Pinar Ozgen Kiratli, Jens Kurth, Ana M. Denis-Bacelar, Roland Hustinx, Marianne Patt, Richard L. Wahl, Diana Paez, Francesco Giammarile, Hossein Jadvar, Neeta Pandit-Taskar, Munir Ghesani, Jolanta Kunikowska
The theranostics concept using the same target for both imaging and therapy dates back to the middle of the last century, when radioactive iodine was first used to treat thyroid diseases. Since then, radioiodine has become broadly established clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a51b062c00657596ccc5a183d8bf585c
https://www.ncbi.nlm.nih.gov/pubmed/35450957
https://www.ncbi.nlm.nih.gov/pubmed/35450957
Publikováno v:
Molecular Imaging and Radionuclide Therapy, Vol 24, Iss 2, Pp 47-59 (2015)
Molecular Imaging and Radionuclide Therapy
Molecular Imaging and Radionuclide Therapy
Both benign and malignant diseases of the thyroid are rare in the pediatric and adolescent population, except congenital hypothyroidism. Nuclear medicine plays a major role, both in the diagnosis and therapy of thyroid pathologies. Use of radioactivi
Autor:
Bilge Volkan Salanci, Tamer Aksoy, Funda Aydin, Emel Ceylan Günay, Gonca Kara Gedik, Pinar Ozgen Kiratli, Pelin Özcan Kara, Nedim Gülaldı
Publikováno v:
Nuclear Medicine Seminars. 1:8-14
Autor:
Emel Ceylan Günay, Pelin Özcan Kara, Nedim Gülaldı, Pinar Ozgen Kiratli, Bilge Volkan Salanci, Gonca Kara Gedik, Funda Aydin, Tamer Aksoy
Publikováno v:
Nuclear Medicine Seminars. 1:19-23
Autor:
Gonca Kara Gedik, Bilge Volkan Salanci, Pelin Özcan Kara, Nedim Gülaldı, Funda Aydin, Pinar Ozgen Kiratli, Tamer Aksoy, Emel Ceylan Günay
Publikováno v:
Nuclear Medicine Seminars. 1:75-79
Autor:
Funda Aydin, Pelin Özcan Kara, Tamer Aksoy, Nedim Gülaldı, Emel Ceylan Günay, Bilge Volkan Salanci, Pinar Ozgen Kiratli, Gonca Kara Gedik
Publikováno v:
Nuclear Medicine Seminars. 1:50-56
Autor:
Bilge Volkan Salanci, Funda Aydin, Pelin Özcan Kara, Nedim Gülaldı, Tamer Aksoy, Gonca Kara Gedik, Emel Ceylan Günay, Pinar Ozgen Kiratli
Publikováno v:
Nuclear Medicine Seminars. 1:15-18